In Situ Pulmonary Artery Thrombosis and Low Flow Stasis Artifact in Parenchymal Lung Disease: An Under‐Recognized Phenomenon

Documenti analoghi

• Immature reticulocyte fraction: A novel biomarker of hemodynamic severity in pulmonary arterial hypertension
  di: Adam J. Brownstein, et al.
  Pubblicazione: (2024)
• Relationship of Pulmonary Artery to Aorta Ratio With Pulmonary Vascular Resistance, Compliance, and Outcomes in COPD and Interstitial Lung Disease in PVDOMICS
  di: Matthew D. Jankowich, et al.
  Pubblicazione: (2026)
• A Systematic Literature Review Exploring the Efficacy and Safety of Tadalafil and Sildenafil in Pulmonary Arterial Hypertension
  di: Rajan Saggar, et al.
  Pubblicazione: (2025)
• Pulmonary Hypertension Associated With COVID‐19 Interstitial Lung Disease
  di: Shreeya Mehta, et al.
  Pubblicazione: (2026)
• Reply To: “Pulmonary Artery Dilatation in Different Causes of Pulmonary Hypertension”
  di: Caputo Annalisa, et al.
  Pubblicazione: (2025)